von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support

被引:13
|
作者
Nascimbene, Angelo [1 ]
Hilton, Tristan [2 ]
Konkle, Barbara A. [2 ,3 ]
Moake, Joel L. [4 ]
Frazier, O. H. [5 ]
Dong, Jing-fei [2 ,3 ]
机构
[1] Univ Texas Houston, Ctr Adv Heart Failure, Houston, TX 77030 USA
[2] BloodWorks Northwest Res Inst, Seattle, WA USA
[3] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA
[4] Rice Univ, JW Cox Lab Biomed Engn, Houston, TX USA
[5] Baylor Coll Med, Texas Heart Inst, Houston, TX 77030 USA
来源
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.healun.2017.01.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:477 / 479
页数:3
相关论文
共 50 条
  • [31] ADAMTS-13 and bleeding phenotype in von Willebrand disease
    Boender, Johan
    Nederlof, Angelique
    Meijer, Karina
    Mauser-Bunschoten, Evelien P.
    Cnossen, Marjon H.
    Fijnvandraat, Karin
    van der Bom, Johanna G.
    de Meris, Joke
    Gorkom, Britta A. P. Laros-van
    van Galen, Karin P. M.
    Eikenboom, Jeroen
    de Maat, Moniek P. M.
    Leebeek, Frank W. G.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (08) : 1331 - 1339
  • [32] Opposite changes of ADAMTS-13 and von Willebrand factor after cardiac surgery
    Mannucci, PM
    Parolari, A
    Canciani, MT
    Alemanni, F
    Camerat, M
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (02) : 397 - 399
  • [33] The sensitive detection of antibodies to von Willebrand factor cleaving protease (ADAMTS-13)
    Starke, R
    Mackie, I
    Purdy, G
    Scully, M
    Machin, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 17 - 17
  • [34] ADAMTS-13 activity and antigen in commercial von Willebrand factor concentrates.
    Scharrer, I
    Böhm, M
    BLOOD, 2005, 106 (11) : 86B - 87B
  • [35] ADAMTS-13 Has a Disulfide Bond Reduction Activity on Von Willebrand Factor
    Zhou, Zhou
    Choi, Hiuwan
    Tao, Zhenyin
    Aboulfatova, Khatira
    Nolasco, Leticia
    Moake, Joel L.
    Dong, Jing-fei
    BLOOD, 2008, 112 (11) : 1340 - 1340
  • [36] Prospective evaluation of ADAMTS-13 and von Willebrand factor multimers in cardiac surgery
    Reinecke, Imke R.
    Weber, Christian F.
    Budde, Ulrich
    Seifried, Erhard
    Miesbach, Wolfgang A.
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (08) : 886 - 891
  • [37] Impact of von Willebrand factor and ADAMTS-13 on the pro-coagulant imbalance of patients with cirrhosis
    La Mura, V.
    Tripodi, A.
    Bitto, N.
    Tosetti, G.
    Chantarangkul, V.
    Baronciani, L.
    Valsecchi, C.
    Peyvandi, F.
    Salerno, F.
    Lampertico, P.
    Colombo, M.
    Primignani, M.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E34 - E34
  • [38] The activity of the von Willebrand factor cleaving protease ADAMTS-13 in newborn infants
    Schmugge, M
    Dunn, MS
    Amankwah, KS
    Blanchette, VS
    Freedman, J
    Rand, ML
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (02) : 228 - 233
  • [39] Toward a Standard Practice to Quantify von Willebrand Factor Degradation During Left Ventricular Assist Device Support
    Hennessy-Strahs, Samson
    Bermudez, Christian A.
    Acker, Michael A.
    Bartoli, Carlo R.
    ANNALS OF THORACIC SURGERY, 2021, 112 (04): : 1257 - 1264
  • [40] Factor VIII concentrate infusion in patients with haemophilia results in decreased von Willebrand factor and ADAMTS-13 activity
    van Bladel, E. R.
    Tuinenburg, A.
    Roest, M.
    de Groot, P. G.
    Schutgens, R. E. G.
    HAEMOPHILIA, 2014, 20 (01) : 92 - 98